AstraZeneca drug combo gets US nod to treat a type of prostate cancer - Reuters

gomotar.blogspot.com

• Companies

• AstraZeneca PLC

June 1 (Reuters) - AstraZeneca (AZN.L) said on Thursday that a combination of its cancer drug Lynparza and abiraterone has been approved in the United States for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer.

The company said the combination treatment reduced the risk of disease progression or death by 76% compared with usage of abiraterone alone.

Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Savio D'Souza

Our Standards: The Thomson Reuters Trust Principles.

Adblock test (Why?)

"type" - Google News
June 01, 2023 at 10:17PM
https://ift.tt/PeBCS2z

AstraZeneca drug combo gets US nod to treat a type of prostate cancer - Reuters
"type" - Google News
https://ift.tt/XCnht5q
https://ift.tt/0ZjXA8V

Bagikan Berita Ini